
The Office of Science Technology and Policy (OSTP) requests input from all interested parties on the U.S. Bioeconomy. According to OSTP, “the Bioeconomy represents the infrastructure, innovation, products, technology, and data derived from biologically-related processes and science that drive economic growth, promote health, and increase public benefit.”
Through this Request for Information (RFI), OSTP seeks input from the public, including those with capital investments, performing innovative research, or developing enabling platforms and applications in the field of biological sciences, to include healthcare, medicine, pharmaceuticals, biotechnology, manufacturing, energy production, and agriculture.
This RFI will inform notable gaps, vulnerabilities, and areas to promote and protect in the U.S. Bioeconomy that may benefit from Federal government attention.
The information can include suggestions on those areas of greatest priority within the Bioeconomy, as well as past or future Federal government efforts to build, promote, and sustain the U.S. Bioeconomy. The public input provided in response to this RFI will inform the Executive Office of the President as well as private sector, academia, non-governmental entities, and other stakeholders with interest in and expertise relating to the promotion of a Bioeconomy ecosystem encompassing shared values and core American principles.
Interested persons are invited to submit comments on or before 11:59 p.m. (ET) on October 22, 2019. Comments submitted in response to OSTP’s notice may be submitted online to: MBX.OSTP.WHBioeconomy@ostp.eop.gov. Email submissions should be machine-readable [pdf, word] and not be copy-protected. Submissions should include ‘‘RFI Response: Bioeconomy’’ in the subject line of the message. Each individual or institution is requested to submit only one response. Submission must not exceed 10 pages in 12 point or larger font, with a page number provided on each page.
Responses should include the name of the person(s) or organization(s) filing the comment.